Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

170
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
170
Inhaled Medications01:23

Inhaled Medications

212
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
212
Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

2.5K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
2.5K
Chronic Obstructive Pulmonary Disease-I: Introduction01:20

Chronic Obstructive Pulmonary Disease-I: Introduction

2.7K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.7K
Drugs Used in Lower Respiratory Disorders: Overview01:17

Drugs Used in Lower Respiratory Disorders: Overview

332
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
332
Chronic Obstructive Pulmonary Disease01:22

Chronic Obstructive Pulmonary Disease

1.1K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Menthol inhalation relieves dyspnoea through the brain.

ERJ open research·2026
Same author

Effects of high- versus moderate-intensity multimodal whole-body training to improve inspiratory muscle function in persons with chronic nonspecific low back pain.

BMC sports science, medicine & rehabilitation·2026
Same author

Reproducibility of the 6-Minute Walk Test on a 20-Metre Course in Community Dwelling Adults With Chronic Obstructive Pulmonary Disease.

Physiotherapy Canada. Physiotherapie Canada·2026
Same author

Reply: Why fan therapy does not yet demonstrate enhanced training benefits in people with chronic respiratory disease.

The European respiratory journal·2026
Same author

The Impact of Neighborhood Material and Social Disadvantage on Respiratory Health Across Canada.

The European respiratory journal·2026
Same author

Reply regarding the European Respiratory Society and European Society of Thoracic Surgeons clinical practice guideline on fitness for curative intent treatment of lung cancer.

The European respiratory journal·2026

Related Experiment Video

Updated: May 22, 2025

Home-Based Prescribed Pulmonary Exercise in Patients with Stable Chronic Obstructive Pulmonary Disease
00:07

Home-Based Prescribed Pulmonary Exercise in Patients with Stable Chronic Obstructive Pulmonary Disease

Published on: August 24, 2019

9.6K

Inhaled Menthol for Dyspnea Relief During Cycle Exercise in COPD: A Randomized Trial.

Michele R Schaeffer1, Lucas Vanden Bossche2, Kaat Beckers1

  • 1Research Group for Rehabilitation in Internal Disorders, Department of Rehabilitation Sciences, KU Leuven, Leuven, Belgium.

Chest
|March 15, 2025
PubMed
Summary
This summary is machine-generated.

Menthol inhalation (MI) reduced breathing discomfort during exercise in COPD patients. While not improving exercise duration, MI made inspiratory airflow feel easier for most participants.

Keywords:
COPDdyspneaexercisementhol

More Related Videos

Author Spotlight: Integrating Alveolar-Capillary Reserve Measurements in Exercise Adaptation and Therapeutic Strategies
08:44

Author Spotlight: Integrating Alveolar-Capillary Reserve Measurements in Exercise Adaptation and Therapeutic Strategies

Published on: February 2, 2024

609
Author Spotlight: Evaluating the Therapeutic Efficacy of Moving Cupping Along Meridians for Acute Exacerbation of COPD
04:03

Author Spotlight: Evaluating the Therapeutic Efficacy of Moving Cupping Along Meridians for Acute Exacerbation of COPD

Published on: September 27, 2024

562

Related Experiment Videos

Last Updated: May 22, 2025

Home-Based Prescribed Pulmonary Exercise in Patients with Stable Chronic Obstructive Pulmonary Disease
00:07

Home-Based Prescribed Pulmonary Exercise in Patients with Stable Chronic Obstructive Pulmonary Disease

Published on: August 24, 2019

9.6K
Author Spotlight: Integrating Alveolar-Capillary Reserve Measurements in Exercise Adaptation and Therapeutic Strategies
08:44

Author Spotlight: Integrating Alveolar-Capillary Reserve Measurements in Exercise Adaptation and Therapeutic Strategies

Published on: February 2, 2024

609
Author Spotlight: Evaluating the Therapeutic Efficacy of Moving Cupping Along Meridians for Acute Exacerbation of COPD
04:03

Author Spotlight: Evaluating the Therapeutic Efficacy of Moving Cupping Along Meridians for Acute Exacerbation of COPD

Published on: September 27, 2024

562

Area of Science:

  • Pulmonary Medicine
  • Respiratory Physiology

Background:

  • Menthol inhalation (MI) is known to reduce dyspnea during loaded breathing in COPD and exercise in healthy individuals.
  • Proposed mechanisms involve cold receptor stimulation, modulating breathing effort perception and airflow.

Purpose of the Study:

  • To investigate if menthol inhalation (MI) alleviates exertional dyspnea in patients with Chronic Obstructive Pulmonary Disease (COPD).

Main Methods:

  • Twenty COPD patients underwent two constant-load cycle exercise tests to exhaustion.
  • Tests were performed with either menthol or placebo (strawberry flavoring) in a counterbalanced order.
  • Dyspnea intensity, unpleasantness, and sensory qualities were assessed using Borg scale and Multidimensional Dyspnea Profile.

Main Results:

  • Menthol inhalation significantly lowered serial dyspnea intensity ratings compared to placebo (P = .01).
  • Ratings of dyspnea unpleasantness, air hunger, and mental breathing effort were reduced at end exercise (P < .05).
  • Menthol did not affect ventilatory or neuromuscular parameters or exercise endurance time.

Conclusions:

  • Menthol inhalation may be a beneficial management strategy for exertional dyspnea in select COPD patients.
  • Further research is recommended to explore MI's potential role in improving exercise rehabilitation outcomes for COPD.